ストックスクリーナーアプリを入手
213.15
3.79%
7.79
アフターアワーズ：
213.15
前日終値:
$205.36
開ける：
$207.68
24時間の取引高:
938.50K
Relative Volume:
0.84
時価総額：
$15.18B
収益：
$2.88B
当期純損益:
$499.60M
株価収益率:
31.62
EPS:
6.74
ネットキャッシュフロー:
$321.60M
1週間 パフォーマンス:
+0.88%
1か月 パフォーマンス:
+5.80%
6か月 パフォーマンス:
-34.09%
1年 パフォーマンス:
-42.13%
1日の値動き範囲:
$207.06
$214.15
1週間の範囲:
$204.78
$215.05
52週間の値動き範囲:
$187.43
$372.52
West Pharmaceutical Services Inc Stock (WST) Company Profile
名前
West Pharmaceutical Services Inc
セクター
電話
(610) 594-2900
住所
530 HERMAN O. WEST DRIVE, EXTON, PA
WST を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
213.15 | 15.18B | 2.88B | 499.60M | 321.60M | 6.74 |
|
ISRG
Intuitive Surgical Inc
|
536.15 | 184.87B | 8.71B | 2.48B | 1.75B | 6.82 |
|
ALC
Alcon Inc
|
96.10 | 48.28B | 9.91B | 1.02B | 665.00M | 2.05 |
|
BDX
Becton Dickinson Co
|
167.14 | 47.99B | 20.87B | 1.50B | 2.59B | 5.24 |
|
RMD
Resmed Inc
|
244.70 | 35.94B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
81.25 | 16.18B | 3.90B | 392.30M | 288.10M | 1.95 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-18 | 開始されました | Evercore ISI | Outperform |
| 2025-02-14 | アップグレード | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 開始されました | Citigroup | Buy |
| 2024-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2024-12-12 | アップグレード | UBS | Neutral → Buy |
| 2024-02-07 | アップグレード | Jefferies | Hold → Buy |
| 2023-06-16 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-04-11 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 開始されました | Deutsche Bank | Hold |
| 2022-11-30 | 開始されました | UBS | Neutral |
| 2022-10-28 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 開始されました | Stephens | Equal-Weight |
| 2020-07-21 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-04-24 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | ダウングレード | Jefferies | Buy → Hold |
| 2019-04-23 | 開始されました | William Blair | Outperform |
| 2018-04-25 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 開始されました | Goldman | Neutral |
| 2017-10-17 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 開始されました | Stephens | Equal-Weight |
| 2017-09-15 | アップグレード | Jefferies | Hold → Buy |
| 2016-10-28 | アップグレード | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 開始されました | Wells Fargo | Outperform |
| 2010-05-14 | 繰り返されました | UBS | Neutral |
| 2010-02-23 | 開始されました | Jefferies & Co | Buy |
| 2008-12-19 | 開始されました | UBS | Neutral |
すべてを表示
West Pharmaceutical Services Inc (WST) 最新ニュース
Shareholder Alert: Robbins LLP Informs Investors of the West Pharmaceutical Services, Inc. Class Action Lawsuit - PR Newswire
West to Participate in Upcoming Investor Conferences - The Victoria Advocate
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
Levi & Korsinsky Notifies Shareholders of West Pharmaceutical Services, Inc. (WST) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Long-Term Shareholder Alert: If You Hold AppLovin Corporation (NASDAQ: APP); Maison Solutions, Inc. (NASDAQ: MSS); Monolithic Power Systems, Inc. (NASDAQ: MPWR); or West Pharmaceutical Services, Inc. (NYSE: WST), Contact Grabar Law Office Tod - TradingView
West Pharmaceutical Services, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationWST - ACCESS Newswire
WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against West Pharmaceutical Services, Inc. (WST) - TradingView
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming DeadlinesWST - PR Newswire
WST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
WST INVESTOR ALERT: West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead the West Pharmaceutical Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
Investors Sue West Pharma Over Post-COVID Stock Losses - Law360
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services - Business Wire
West Pharma Sued After SmartDose Device Stock Drop, Fiscal Hit - Bloomberg Law News
Shareholders that Lost Money on West Pharmaceutical Services, Inc.(WST) Should Contact Levi & Korsinsky About Securities Fraud InvestigationWST - ACCESS Newswire
Labaton Keller Sucharow LLP Announces Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. and Certain of Its Executives - Business Wire
West Pharmaceutical Services, Inc. Investigated Regarding Potential Securities Law ViolationsContact Levi & Korsinsky for Details- WST - ACCESS Newswire
West Pharmaceutical Services: Will Its SmartDose Technology Development Enhance The Business Segment's Competitive Positioning? - Smartkarma
Is West Pharmaceutical Services, Inc (WST) positioned for future growth? - Sete News
West Pharmaceutical Services (WST) Fell on Disappointing Guidance - Insider Monkey
Press Release Distribution & PR Platform - ACCESS Newswire
Here’s Why West Pharmaceutical Services (WST) Stock Fell 38% - Insider Monkey
The Best Healthcare Stocks to Buy - Morningstar
BlackRock, Inc. Reduces Stake in West Pharmaceutical Services Inc. - GuruFocus
11 Worst Performing Stocks in S&P 500 So Far in 2025 - Insider Monkey
West Pharmaceutical Services, Inc. (WST): Among the Worst Performing Stocks in S&P 500 So Far in 2025 - Insider Monkey
Market Update: West Pharmaceutical Services, Inc (WST) Sees Negative Movement, Closing at 213.46 - DWinneX
West Pharmaceutical Services First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
It Looks Like West Pharmaceutical Services, Inc.'s (NYSE:WST) CEO May Expect Their Salary To Be Put Under The Microscope - simplywall.st
The Potential Rise in the Price of West Pharmaceutical Services, Inc (WST) following insiders activity - knoxdaily.com
West Pharmaceutical Services Earnings: What To Look For From WST - MSN
Did West Pharmaceutical Services, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky InvestigateWST - ACCESS Newswire
Exton’s West Pharmaceuticals Braces for $25 Million Tariff Bite - VISTA.Today
Ex-Dividend Reminder: West Pharmaceutical Services, Agree Realty and Citizens Financial Group - Nasdaq
What is William Blair’s Estimate for WST Q3 Earnings? - Defense World
West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2025 Earnings Call Transcript - MSN
West pharmaceutical increases FY 2025 revenue guidance to $2.975B - MSN
Decoding West Pharmaceutical Services Inc (WST): A Strategic SWO - GuruFocus
West Pharmaceutical Services and Philadelphia Eagles Partner for Earth Day Initiative - MSN
West Pharmaceutical Services Earnings Call: Mixed Sentiments and Strategic Shifts - TipRanks
West Pharmaceutical Services, Inc [WST] Shares Fall Approximately -43.90% Over the Year - knoxdaily.com
Jefferies & Co Adjusts West Pharmaceutical Services Price Target to $245 From $240, Maintains Buy Rating - marketscreener.com
WST Stock Rises on Q1 Earnings Beat, EPS View Up on Tariff & FX Benefit - MSN
West Pharmaceutical: Q1 Earnings Snapshot - Huron Daily Tribune
West Pharmaceutical Services Reports Q1 2025 Earnings - TipRanks
West Pharmaceutical Q1 2025 slides: Sales edge up while EPS declines By Investing.com - Investing.com South Africa
West Pharmaceutical Services (WST) Raises 2025 Outlook Following Strong Q1 Results - GuruFocus
West Pharmaceutical Defies Doubters: EPS Jumps, Outlook Raised Despite Tariff Drag - Benzinga
West Pharmaceutical Q1 2025 slides: Sales edge up while EPS declines - Investing.com India
West Pharmaceutical Services, Inc: Weathering Stock Market Storms with 15.33B Market Cap - investchronicle.com
West Pharmaceutical Services Inc (WST) 財務データ
収益
当期純利益
現金流量
EPS
2.64%
0.49%
大文字化:
|
ボリューム (24 時間):